Open Journal of Blood Diseases
Vol.3 No.1(2013), Paper ID 29197, 7
pages
DOI:10.4236/ojbd.2013.31002
Clinical Significance of Pulmonary Function Tests in Long-Term Survivors after Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation
Kenji Matsumoto, Satomi Ito, Wataru Yamamoto, Eriko Ogusa, Atsuo Maruta, Yoshiaki Ishigatsubo, Heiwa Kanamori
Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
Department Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
Department Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
Copyright © 2013 Kenji Matsumoto, Satomi Ito, Wataru Yamamoto, Eriko Ogusa, Atsuo Maruta, Yoshiaki Ishigatsubo, Heiwa Kanamori et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
K. Matsumoto, S. Ito, W. Yamamoto, E. Ogusa, A. Maruta, Y. Ishigatsubo and H. Kanamori, "Clinical Significance of Pulmonary Function Tests in Long-Term Survivors after Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation,"
Open Journal of Blood Diseases, Vol. 3 No. 1, 2013, pp. 6-12. doi:
10.4236/ojbd.2013.31002.